Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2014
03/13/2014WO2014037588A2 Methods and compounds for preventing, treating and diagnosing an inflammatory condition
03/13/2014WO2014037519A2 Compositions and methods
03/13/2014WO2014037419A1 Immunoglobulin single variable domains directed against cd74 and uses derived thereof
03/13/2014WO2014037316A1 Combination treatment of cancer
03/13/2014WO2014036645A1 Picornavirus-like particle production in plants
03/13/2014WO2014036608A1 Methods and products for preventing and/or treating metastatic cancer
03/13/2014WO2014015966A3 Spherical magnetisable polyvinyl alcohol microparticles, method for producing same, and use thereof
03/13/2014WO2014014897A3 Immunoglobulin-binding human mycoplasma antigens and methods of use thereof
03/13/2014WO2014004549A3 Anti-mesothelin binding proteins
03/13/2014WO2013181461A3 Metal abstraction peptide with superoxide dismutase activity
03/13/2014WO2013164689A3 Humanized pan-her antibody compositions
03/13/2014WO2013158821A3 Methods of treating ankylosing spondylitis using il-17 antagonists
03/13/2014WO2013156534A9 Cross-reactive staphylococcus aureus antibody
03/13/2014US20140075585 Tetraspanin CD82 as a Diagnostic and/or Therapeutic Module for Xenograft Recognition and/or Rejection
03/13/2014US20140073769 Asymmetric porous adsorptive bead
03/13/2014US20140073768 OPTIMIZED Fc VARIANTS
03/13/2014US20140073767 Protein complexes and methods of manufacturing bispecific antibodies using the protein complexes
03/13/2014US20140073766 METHODS FOR PURIFYING IgY ANTIBODIES
03/13/2014US20140073532 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
03/13/2014US20140073047 Connective Tissue Growth Factor Antibodies
03/13/2014US20140073029 Targeted perhydrolases
03/13/2014US20140073010 Methods of Modifying Eukaryotic Cells
03/13/2014US20140073005 Fusion Constructs and Use of Same to Produce Antibodies with Increased Fc Receptor Binding Affinity and Effector Function
03/13/2014US20140072592 Method of preparing antigen for acquiring anti-hydrophobic peptide antibody
03/13/2014US20140072589 North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof
03/13/2014US20140072586 Antibody drug conjugates (adc) that bind to 158p1d7 proteins
03/13/2014US20140072583 Methods for treating atopic dermatitis by administering an il-4r antagonist
03/13/2014US20140072582 Molecules with antigen binding and polyvalent fc gamma receptor binding activity
03/13/2014US20140072581 Immunoglobulin Constructs Comprising Selective Pairing of the Light and Heavy Chains
03/13/2014US20140072579 Methods and means for the production of ig-like molecules
03/13/2014US20140072578 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
03/13/2014US20140072577 Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
03/13/2014US20140072575 Rsv-specific binding molecules and means for producing them
03/13/2014US20140072572 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs
03/13/2014US20140072570 Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab
03/13/2014US20140072569 Emp2 antibodies and their therapeutic uses
03/13/2014US20140072568 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1)
03/13/2014US20140072567 Methods Of Treating And Preventing Glucose Toxicity
03/13/2014US20140072566 Novel epitope for switching to th2 cell and use thereof
03/13/2014US20140072565 Novel epitope for switching to th17 cell and use thereof
03/13/2014US20140072564 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
03/13/2014US20140072563 Methods and Compositions Comprising a Combination of an Anti-ErbB3 Antibody and an Anti-EGFR Antibody
03/13/2014US20140072560 Correctly folded etanercept in high purity and excellent yield
03/13/2014US20140072553 High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B
03/13/2014US20140072551 Anti-P-Selectin Antibodies and Methods of Using The Same to Treat Inflammatory Diseases
03/13/2014US20140072511 Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy
03/12/2014EP2706116A1 Binding domain-immunoglobulin fusion proteins
03/12/2014EP2706070A1 Combination treatments involving antibodies to human PCSK9
03/12/2014EP2706069A1 Protein complexes and methods of manufacturing bispecific antibodies using the protein complexes
03/12/2014EP2705846A2 Methods for reducing allergies caused by environmental allergens
03/12/2014EP2705147A1 Amino acid sequence presenting fusion polypeptide and its use
03/12/2014EP2705058A1 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
03/12/2014EP2705057A1 Therapeutic canine immunoglobulins and methods of using the same
03/12/2014EP2705056A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
03/12/2014EP2705055A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
03/12/2014EP2705054A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
03/12/2014EP2705053A1 An antibody specifically binding to insulin-like growth factor-1
03/12/2014EP2704798A2 Formulation for anti- alpha4beta7 antibody
03/12/2014EP2704743A1 Compositions for inhibiting masp-2 dependent complement acitivation
03/12/2014EP2704739A1 Recombinant immunotoxin targeting mesothelin
03/12/2014CN103635806A Method of obtaining a binder to prepro-vasopressin or fragments thereof
03/12/2014CN103635490A Soluble proteins for use as therapeutics
03/12/2014CN103635489A Plasma kallikrein binding proteins
03/12/2014CN103635488A Anti-CD40 antibodies and methods of use
03/12/2014CN103635487A Selective elimination of erosive cells
03/12/2014CN103635486A HLA-restricted, peptide-specific antigen binding proteins
03/12/2014CN103635204A CETP fragments
03/12/2014CN103627677A Lp(a) (Lipoprotein(a)) resisting monoclonal antibody and latex-enhanced immunonephelometric detection kit for Lp(a)
03/12/2014CN103627676A Physarum polycephalum 14-3-3 protein monoclonal antibodies and preparation method thereof
03/12/2014CN103626874A Method for preparing polyclonal antibody for resisting human BTF (Bcl-2-associated transcription factor 1)
03/12/2014CN103626873A Beta-1 adrenergic receptor monoclonal antibody for inducing myocardial cell apoptosis
03/12/2014CN103626872A Method for screening antibody J7 of insert domain mu(alpha)L Id of mouse integrin LFA-1 (Lymphocyte Function associated Antigen-1) molecule
03/12/2014CN103626871A Monoclonal antibodies capable of specifically recognizing EGFR mutant protein, preparation method and application thereof
03/12/2014CN103626870A Preparation method for monoclonal antibody for treating head and neck tumor
03/12/2014CN103626869A Method for preparing sheep myostatin (MSTN) gene monoclonal antibody vaccines
03/12/2014CN103626868A Serratia fonticola polyclonal antiserum as well as preparation method and application thereof in detection of salmonellae
03/12/2014CN103626865A Secreted protein with chemotactic activity, as well as coding sequence and medicament usage thereof
03/12/2014CN103623408A Low dose methods for treating disorders in which tnf dollar g(a) activity is detrimental
03/12/2014CN103073644B Specific anti-mouse TIGIT monoclonal antibody and preparation method, identification and application thereof
03/12/2014CN102766207B Bactrian camel heavy-chain (HC) variable-domain antibody resisting porcine circovirus 2 as well as preparation method and application thereof
03/12/2014CN102741272B Peptides inhibiting adhesion of aspergillus fumigatus to cornea
03/12/2014CN102584947B Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
03/12/2014CN102532312B Anti-Vibrio anguillarum yolk antibody, and preparation method, titer detection method and application thereof
03/12/2014CN102360015B Anti-alzheimer's disease monoclonal antibody and application thereof
03/12/2014CN102202692B Method for diagnosing cancers expressing HER2 receptor or its truncated variants
03/12/2014CN102178951B Method for producing intravenous injection human immune globulin
03/12/2014CN102066552B Cellular production of glucaric acid
03/12/2014CN101949921B Heavy metal enzyme label and application thereof
03/12/2014CN101946171B Fluorescent compounds
03/12/2014CN101861521B High sensitivty immunoassays and kits for determination of peptides and proteins of biological interest
03/12/2014CN101827609B High affinity human antibodies to human nerve growth factor
03/12/2014CN101796415B Novel liver cancer marker
03/12/2014CN101679966B Genetically recombinant antibody composition having enhanced effector activity
03/12/2014CN101679521B Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
03/12/2014CN101418044B Immunoglobulin variants and uses thereof
03/12/2014CN101261277B Promyostatin peptides and methods of using same
03/11/2014US8669353 Process for producing milk fractions rich in secretory immunoglobulins
03/11/2014US8669352 Antagonistic anti-human CD40 monoclonal antibody
03/11/2014US8669351 Antibodies to polypeptides encoded by aspartoacylase polynucleotides
03/11/2014US8669349 BCR-complex-specific antibodies and methods of using same
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 1494